Abstract:Esophageal cancer (EC) is one of the most life-threatening malignancies worldwide. Esophageal squamous cell carcinoma (ESCC) is the dominant subtype, accounting for approximately 90% of new incident EC each year. Although multidisciplinary treatment strategies have advanced rapidly, patients with ESCC are often diagnosed at advanced stage and the long-term prognosis remains unsatisfactory. In recent decades, immunotherapy, such as immune checkpoint inhibitors (ICIs), tumor vaccines, and chimeric antigen receptor T-cell (CAR-T) therapy, has been successfully used in clinical practice as a novel therapy for treating tumors, bringing new hope to ESCC patients. However, only a small fraction of patients achieved clinical benefits due to primary or acquired resistance. Immune evasion plays a pivotal role in the initiation and progression of ESCC. Therefore, a thorough understanding of the mechanisms by which ESCC cells escape from anti-tumor immunity is necessary for a more effective multidisciplinary treatment strategy. It has been widely recognized that immune evasion is closely associated with the crosstalk between tumor cells and the tumor microenvironment (TME). TME is a dynamic complex and comprehensive system including not only cellular components but also non-cellular components, which influence hallmarks and fates of tumor cells from the outside. Novel immunotherapy targeting tumor-favorable TME represents a promising strategy to achieve better therapeutic responses for patients with ESCC. In this review, we provide an overview of immune evasion in ESCC, mainly focusing on the molecular mechanisms that underlie the role of TME in immune evasion of ESCC. In addition, we also discuss the challenges and opportunities of precision therapy for ESCC by targeting TME.

Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer

Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer

Roles of cancer stem cells in gastrointestinal cancers

Potential markers of cancer stem-like cells in esophageal squamous cell carcinoma: A review of the current knowledge

Targeting esophageal carcinoma: molecular mechanisms and clinical studies

Esophageal cancer: emerging therapeutics

Cancer stem cells: advances in knowledge and implications for cancer therapy

Advances in targeted therapy for esophageal cancer

EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy

Cancer Stem Cells from Definition to Detection and Targeted Drugs

Cancer stem cells: a target for overcoming therapeutic resistance and relapse

Advances and challenges in the treatment of esophageal cancer

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

Emerging Role of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma

Lung cancer stem cells: tools and targets to fight lung cancer

Targeting Cancer Stem Cells and Their Niche: Perspectives for Future Therapeutic Targets and Strategies

Advances in targeted therapy and immunotherapy for esophageal cancer

Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment